You experience symptoms that could indicate a side effect, such as drowsiness, upset stomach, or dizziness, which could signal that the combination is affecting your central nervous system or blood pressure
GLP-1 agonists demonstrate potential beyond metabolic benefits, targeting inflammatory mechanisms underlying ulcerative colitis through pathways observed in preclinical research. For overweight patients with ulcerative colitis, these medications offer dual benefits: reducing inflammation while facilitating weight loss , which itself may decrease disease activity
Heartburn and acid reflux may occur due to delayed gastric emptying
HAMI3379 was from Cayman Chemical (Item no
coli strain BL21 following induction with IPTG
System xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS